G9a/DNMT1 co-targeting inhibits NSCLC growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1

ID: 2326

Autores: Calvo, Alfonso (0); Exposito, Francisco  (1,2,3); Redrado, Miriam  (1,3); Serrano, Diego  (1,2,3); Calabuig, Silvia (2,4); Bao-Caamano, Aida  (5); Jantus-Lewintre, Eloisa  (2,6); Diaz-Lagares, Angel  (2,5); Sandoval, Juan  (7); San Jose-Eneriz, Edune  (2,3,8); Senent, Yaiza (1,3); Leon, Sergio (1); Pio, Ruben  (1,2,3); Lopez, Rafael  (2,5); Pineda, Antonio  (9); Agirre, Xavier  (2,3,8); Montuenga, Luis  (1,2,3); Prosper, Felipe  (2,3,8); Calvo, Alfonso (1,2,3)

Temática: New frontiers in treatment/Precision medicine

Etiquetas: